Onconetix Seeks Shareholder Approval for Another Reverse Stock Split to Maintain Nasdaq Listing

summarizeSummary

Onconetix is seeking shareholder approval for additional reverse stock split authority, a move necessitated by its ongoing failure to meet Nasdaq's minimum bid price requirement, further compounding concerns raised by its recent 'going concern' disclosure.

check_boxKey Events

• New Reverse Stock Split Proposal

  Shareholders will vote on granting the Board discretionary authority to effect one or more reverse stock splits at a ratio of 1-for-2 to 1-for-10, with an aggregate limit of 1-for-100, to be completed within one year.

• Persistent Nasdaq Non-Compliance

  The company's 30-day trailing closing bid price was below $1.00 as of March 17, 2026, indicating a renewed struggle to meet Nasdaq's minimum bid price rule despite a previous 1-for-85 reverse split in June 2025.

• Follows Prior Reverse Split Authorization

  This new proposal comes after shareholders already approved a reverse stock split authority (1-for-2 to 1-for-50) on February 3, 2026, which has not yet been implemented, signaling a continuous need for such measures.

• Context of Going Concern Warning

  This filing closely follows the company's 10-K on March 13, 2026, which disclosed substantial doubt about its ability to continue as a going concern and material weaknesses in internal controls, underscoring the severity of its financial position.

auto_awesomeAnalysis

Onconetix is requesting shareholder approval for discretionary authority to effect one or more reverse stock splits, ranging from 1-for-2 to 1-for-10, with an aggregate limit of 1-for-100. This proposal comes just five days after the company's 10-K filing disclosed substantial doubt about its ability to continue as a going concern and material weaknesses in internal controls. This marks a continuous struggle for Nasdaq compliance, following a 1-for-85 reverse split in June 2025 and a previously approved (but not yet implemented) reverse split authority in February 2026. The repeated need for reverse splits, despite prior actions, highlights severe underlying financial distress and a persistent inability to maintain its stock price above Nasdaq's minimum bid requirement. This ongoing situation significantly erodes investor confidence and complicates future capital-raising efforts.